Literature DB >> 24760765

Survival motor neuron protein deficiency impairs myotube formation by altering myogenic gene expression and focal adhesion dynamics.

Katherine V Bricceno1, Tara Martinez2, Evgenia Leikina3, Stephanie Duguez4, Terence A Partridge4, Leonid V Chernomordik3, Kenneth H Fischbeck5, Charlotte J Sumner6, Barrington G Burnett7.   

Abstract

While spinal muscular atrophy (SMA) is characterized by motor neuron degeneration, it is unclear whether and how much survival motor neuron (SMN) protein deficiency in muscle contributes to the pathophysiology of the disease. There is increasing evidence from patients and SMA model organisms that SMN deficiency causes intrinsic muscle defects. Here we investigated the role of SMN in muscle development using muscle cell lines and primary myoblasts. Formation of multinucleate myotubes by SMN-deficient muscle cells is inhibited at a stage preceding plasma membrane fusion. We found increased expression and reduced induction of key muscle development factors, such as MyoD and myogenin, with differentiation of SMN-deficient cells. In addition, SMN-deficient muscle cells had impaired cell migration and altered organization of focal adhesions and the actin cytoskeleton. Partially restoring SMN inhibited the premature expression of muscle differentiation markers, corrected the cytoskeletal abnormalities and improved myoblast fusion. These findings are consistent with a role for SMN in myotube formation through effects on muscle differentiation and cell motility. Published by Oxford University Press 2014. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24760765      PMCID: PMC4140458          DOI: 10.1093/hmg/ddu189

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  46 in total

Review 1.  Talin: an emerging focal point of adhesion dynamics.

Authors:  Anjana Nayal; Donna J Webb; Alan F Horwitz
Journal:  Curr Opin Cell Biol       Date:  2004-02       Impact factor: 8.382

2.  Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection.

Authors:  T K Blackwell; H Weintraub
Journal:  Science       Date:  1990-11-23       Impact factor: 47.728

3.  De novo neuromuscular junction formation on human muscle fibres cultured in monolayer and innervated by foetal rat spinal cord: ultrastructural and ultrastructural--cytochemical studies.

Authors:  V Askanas; H Kwan; R B Alvarez; W K Engel; T Kobayashi; A Martinuzzi; E F Hawkins
Journal:  J Neurocytol       Date:  1987-08

4.  Possible pathogenic role of muscle cell dysfunction in motor neuron death in spinal muscular atrophy.

Authors:  Séverine Guettier-Sigrist; Bénédicte Hugel; Gilliane Coupin; Jean-Marie Freyssinet; Philippe Poindron; Jean-Marie Warter
Journal:  Muscle Nerve       Date:  2002-05       Impact factor: 3.217

5.  Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse.

Authors:  P S Jat; M D Noble; P Ataliotis; Y Tanaka; N Yannoutsos; L Larsen; D Kioussis
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

6.  Positive autoregulation of the myogenic determination gene MyoD1.

Authors:  M J Thayer; S J Tapscott; R L Davis; W E Wright; A B Lassar; H Weintraub
Journal:  Cell       Date:  1989-07-28       Impact factor: 41.582

7.  Reduced cell migration and disruption of the actin cytoskeleton in calpain-deficient embryonic fibroblasts.

Authors:  N Dourdin; A K Bhatt; P Dutt; P A Greer; J S Arthur; J S Elce; A Huttenlocher
Journal:  J Biol Chem       Date:  2001-10-15       Impact factor: 5.157

8.  Reduced expression of nicotinic AChRs in myotubes from spinal muscular atrophy I patients.

Authors:  Anne-Sophie Arnold; Mor Gueye; Séverine Guettier-Sigrist; Isabelle Courdier-Fruh; Gilliane Coupin; Philippe Poindron; Jean-Pierre Gies
Journal:  Lab Invest       Date:  2004-10       Impact factor: 5.662

9.  Identification and characterization of a spinal muscular atrophy-determining gene.

Authors:  S Lefebvre; L Bürglen; S Reboullet; O Clermont; P Burlet; L Viollet; B Benichou; C Cruaud; P Millasseau; M Zeviani
Journal:  Cell       Date:  1995-01-13       Impact factor: 41.582

10.  Aberrant regulation of MyoD1 contributes to the partially defective myogenic phenotype of BC3H1 cells.

Authors:  T J Brennan; D G Edmondson; E N Olson
Journal:  J Cell Biol       Date:  1990-04       Impact factor: 10.539

View more
  33 in total

1.  Low levels of Survival Motor Neuron protein are sufficient for normal muscle function in the SMNΔ7 mouse model of SMA.

Authors:  Chitra C Iyer; Vicki L McGovern; Jason D Murray; Sara E Gombash; Phillip G Zaworski; Kevin D Foust; Paul M L Janssen; Arthur H M Burghes
Journal:  Hum Mol Genet       Date:  2015-08-13       Impact factor: 6.150

2.  The Power of Human Protective Modifiers: PLS3 and CORO1C Unravel Impaired Endocytosis in Spinal Muscular Atrophy and Rescue SMA Phenotype.

Authors:  Seyyedmohsen Hosseinibarkooie; Miriam Peters; Laura Torres-Benito; Raphael H Rastetter; Kristina Hupperich; Andrea Hoffmann; Natalia Mendoza-Ferreira; Anna Kaczmarek; Eva Janzen; Janine Milbradt; Tobias Lamkemeyer; Frank Rigo; C Frank Bennett; Christoph Guschlbauer; Ansgar Büschges; Matthias Hammerschmidt; Markus Riessland; Min Jeong Kye; Christoph S Clemen; Brunhilde Wirth
Journal:  Am J Hum Genet       Date:  2016-08-04       Impact factor: 11.025

3.  Reorganization of the nuclear compartments involved in transcription and RNA processing in myonuclei of type I spinal muscular atrophy.

Authors:  María S Castillo-Iglesias; María T Berciano; J Oriol Narcis; J Fernando Val-Bernal; José C Rodriguez-Rey; Olga Tapia; Miguel Lafarga
Journal:  Histochem Cell Biol       Date:  2019-06-11       Impact factor: 4.304

4.  Muscle-specific SMN reduction reveals motor neuron-independent disease in spinal muscular atrophy models.

Authors:  Jeong-Ki Kim; Narendra N Jha; Zhihua Feng; Michelle R Faleiro; Claudia A Chiriboga; Lan Wei-Lapierre; Robert T Dirksen; Chien-Ping Ko; Umrao R Monani
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

5.  Central and peripheral delivered AAV9-SMN are both efficient but target different pathomechanisms in a mouse model of spinal muscular atrophy.

Authors:  Aoife Reilly; Marc-Olivier Deguise; Ariane Beauvais; Rebecca Yaworski; Simon Thebault; Daniel R Tessier; Vincent Tabard-Cossa; Niko Hensel; Bernard L Schneider; Rashmi Kothary
Journal:  Gene Ther       Date:  2022-04-25       Impact factor: 4.184

6.  Age-dependent SMN expression in disease-relevant tissue and implications for SMA treatment.

Authors:  Daniel M Ramos; Constantin d'Ydewalle; Vijayalakshmi Gabbeta; Amal Dakka; Stephanie K Klein; Daniel A Norris; John Matson; Shannon J Taylor; Phillip G Zaworski; Thomas W Prior; Pamela J Snyder; David Valdivia; Christine L Hatem; Ian Waters; Nikhil Gupte; Kathryn J Swoboda; Frank Rigo; C Frank Bennett; Nikolai Naryshkin; Sergey Paushkin; Thomas O Crawford; Charlotte J Sumner
Journal:  J Clin Invest       Date:  2019-11-01       Impact factor: 14.808

7.  Chronic Treatment with the AMPK Agonist AICAR Prevents Skeletal Muscle Pathology but Fails to Improve Clinical Outcome in a Mouse Model of Severe Spinal Muscular Atrophy.

Authors:  Clàudia Cerveró; Neus Montull; Olga Tarabal; Lídia Piedrafita; Josep E Esquerda; Jordi Calderó
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

8.  Impaired Muscle Mitochondrial Biogenesis and Myogenesis in Spinal Muscular Atrophy.

Authors:  Michela Ripolone; Dario Ronchi; Raffaella Violano; Dionis Vallejo; Gigliola Fagiolari; Emanuele Barca; Valeria Lucchini; Irene Colombo; Luisa Villa; Angela Berardinelli; Umberto Balottin; Lucia Morandi; Marina Mora; Andreina Bordoni; Francesco Fortunato; Stefania Corti; Daniela Parisi; Antonio Toscano; Monica Sciacco; Salvatore DiMauro; Giacomo P Comi; Maurizio Moggio
Journal:  JAMA Neurol       Date:  2015-06       Impact factor: 18.302

9.  SMN Protein Contributes to Skeletal Muscle Cell Maturation Via Caspase-3 and Akt Activation.

Authors:  Shiori Ando; Miruto Tanaka; Naoki Chinen; Shinsuke Nakamura; Masamitsu Shimazawa; Hideaki Hara
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

Review 10.  In Search of a Cure: The Development of Therapeutics to Alter the Progression of Spinal Muscular Atrophy.

Authors:  Kristine S Ojala; Emily J Reedich; Christine J DiDonato; Stephen D Meriney
Journal:  Brain Sci       Date:  2021-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.